Page 253 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 253
P0770 EFFECT OF HEPATITIS C ANTIVIRAL THERAPY ON ePOSTERS
P0771 ALL-CAUSE MORTALITY AND DEVELOPMENT OF CANCER
P0772 IN THE CHRONIC HEPATITIS COHORT STUDY (CHECS)
P0773 Mei Lu, Jia Li, Loralee B. Rupp, Scott D. Holmberg, Anne C. Moorman,
P0774 Philip R. Spradling, Eyasu Teshale, Fujie Xu, Joseph A. Boscarino,
Vinutha Vijayadeva, Mark A. Schmidt, Lois E. Lamerato, Stuart Gordon*,
The United States
C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF
GRAZOPREVIR ± ELBASVIR ± RIBAVIRIN IN PATIENTS
WITH HCV GT2, 4, 5 OR 6 INFECTION
Ashley Brown*, Christophe Hezode, Eli Zuckerman, Graham Foster,
Amany Zekry, Stuart Roberts, Anita Howe, Christine Durkan,
Cyrus Badshah, Boan Zhang, Michael Robertson, Janice Wahl,
Eliav Barr, Barbara Haber, The United Kingdom
DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT
RIBAVIRIN FOR THE TREATMENT OF HCV IN PATIENTS
WITH SEVERE LIVER DISEASE: INTERIM RESULTS OF A
MULTICENTER COMPASSIONATE USE PROGRAM
Tania M. Welzel*, Kerstin Herzer, Peter Ferenci, Joerg Petersen,
Michael Gschwantler, Markus Cornberg, Thomas Berg, Ulrich Spengler,
Ola Weiland, Marc Van der Valk, Hartwig Klinker, Jürgen Rockstroh,
Patrick Ingiliz, Markus Peck-Radosavljevic, Maria Jesus Jimenez-
Exposito, Stefan Zeuzem, Germany
THE PREVALENCE AND THE EFFECT OF HCV NS5A
RESISTANCE ASSOCIATED VARIANTS IN SUBJECTS WITH
COMPENSATED CIRRHOSIS TREATED WITH LEDIPASVIR/
SOFOSBUVIR ± RBV
Christoph Sarrazin*, Hadas Dvory-Sobol, Evguenia S. Svarovskaia,
Brian Doehle, Ross Martin, Stefan Zeuzem, Eric Lawitz, Robert Hyland,
Phil S. Pang, Steven Knox, Edward Gane, Rajender Reddy,
Nezam Afdhal, Masashi Mizokami, Masao Omata, Michael D. Miller,
Hongmei Mo, Marc Bourlière, Germany
LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN IS SAFE IN >600
DECOMPENSATED AND POST LIVER TRANSPLANTATION
PATIENTS WITH HCV INFECTION: AN INTEGRATED
SAFETY ANALYSIS OF THE SOLAR 1 AND SOLAR 2 TRIALS
Didier Samuel*, Michael Manns, Xavier Forns, Steven L. Flamm,
K. R. Reddy, Jill Denning, Sarah Arterburn, Theo Brandt-Sarif,
Phillip S. Pang, John G. McHutchison, Nezam Afdhal, Michael Charlton,
Edward Gane, David Mutimer, Gregory T. Everson, France
Vienna, Austria • April 22–26, 2015 253
P0771 ALL-CAUSE MORTALITY AND DEVELOPMENT OF CANCER
P0772 IN THE CHRONIC HEPATITIS COHORT STUDY (CHECS)
P0773 Mei Lu, Jia Li, Loralee B. Rupp, Scott D. Holmberg, Anne C. Moorman,
P0774 Philip R. Spradling, Eyasu Teshale, Fujie Xu, Joseph A. Boscarino,
Vinutha Vijayadeva, Mark A. Schmidt, Lois E. Lamerato, Stuart Gordon*,
The United States
C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF
GRAZOPREVIR ± ELBASVIR ± RIBAVIRIN IN PATIENTS
WITH HCV GT2, 4, 5 OR 6 INFECTION
Ashley Brown*, Christophe Hezode, Eli Zuckerman, Graham Foster,
Amany Zekry, Stuart Roberts, Anita Howe, Christine Durkan,
Cyrus Badshah, Boan Zhang, Michael Robertson, Janice Wahl,
Eliav Barr, Barbara Haber, The United Kingdom
DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT
RIBAVIRIN FOR THE TREATMENT OF HCV IN PATIENTS
WITH SEVERE LIVER DISEASE: INTERIM RESULTS OF A
MULTICENTER COMPASSIONATE USE PROGRAM
Tania M. Welzel*, Kerstin Herzer, Peter Ferenci, Joerg Petersen,
Michael Gschwantler, Markus Cornberg, Thomas Berg, Ulrich Spengler,
Ola Weiland, Marc Van der Valk, Hartwig Klinker, Jürgen Rockstroh,
Patrick Ingiliz, Markus Peck-Radosavljevic, Maria Jesus Jimenez-
Exposito, Stefan Zeuzem, Germany
THE PREVALENCE AND THE EFFECT OF HCV NS5A
RESISTANCE ASSOCIATED VARIANTS IN SUBJECTS WITH
COMPENSATED CIRRHOSIS TREATED WITH LEDIPASVIR/
SOFOSBUVIR ± RBV
Christoph Sarrazin*, Hadas Dvory-Sobol, Evguenia S. Svarovskaia,
Brian Doehle, Ross Martin, Stefan Zeuzem, Eric Lawitz, Robert Hyland,
Phil S. Pang, Steven Knox, Edward Gane, Rajender Reddy,
Nezam Afdhal, Masashi Mizokami, Masao Omata, Michael D. Miller,
Hongmei Mo, Marc Bourlière, Germany
LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN IS SAFE IN >600
DECOMPENSATED AND POST LIVER TRANSPLANTATION
PATIENTS WITH HCV INFECTION: AN INTEGRATED
SAFETY ANALYSIS OF THE SOLAR 1 AND SOLAR 2 TRIALS
Didier Samuel*, Michael Manns, Xavier Forns, Steven L. Flamm,
K. R. Reddy, Jill Denning, Sarah Arterburn, Theo Brandt-Sarif,
Phillip S. Pang, John G. McHutchison, Nezam Afdhal, Michael Charlton,
Edward Gane, David Mutimer, Gregory T. Everson, France
Vienna, Austria • April 22–26, 2015 253
